DOROTHY FERRELLI: Open Payments
NPI 1356642805 · BLUFFTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366 in 11 payments from 9 companies in 2025. Trend: 2023 $1,290 · 2024 $1,305 · 2025 $366
Food & beverage: $345Education: $21
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $163 |
| Janssen Biotech, Inc. | 2 | $50 |
| Celgene Corporation | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| ABBVIE INC. | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: TECVAYLI, REBLOZYL, OPDIVO, OJJAARA, IMBRUVICA, ELREXFIO, FRUZAQLA.
Industry payments across SC — which companies pay providers there.
